# A Study of Injection HB0025 in Patients With Advanced Solid Tumors

> **NCT04678908** · PHASE1 · UNKNOWN · sponsor: **Huabo Biopharm Co., Ltd.** · enrollment: 154 (estimated)

## Conditions studied

- Tumor, Subjects

## Interventions

- **DRUG:** HB0025

## Key facts

- **NCT ID:** NCT04678908
- **Lead sponsor:** Huabo Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-10
- **Primary completion:** 2024-02-02
- **Final completion:** 2024-05-23
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04678908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04678908, "A Study of Injection HB0025 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04678908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*